Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
Rafael Ríos-Tamayo,1–4 Agustín Martín-García,5,6 Carolina Alarcón-Payer,5 Dolores Sánchez-Rodríguez,1,7 Ana María del Valle Díaz de la Guardia,5 Carlos Gustavo García Collado,5 Alberto Jiménez Morales,5 Manuel Jurado Chacón,1–4 José Cabeza Barrera4,5 1Monoclonal Gammopathies Unit, 2Department of Hem...
Saved in:
Main Authors: | Rios-Tamayo R (Author), Martín-García A (Author), Alarcón-Payer C (Author), Sánchez-Rodríguez D (Author), Guardia AM (Author), García Collado CG (Author), Jiménez Morales A (Author), Jurado Chacón M (Author), Cabeza Barrera J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA
by: M. Yu. Frolov, et al.
Published: (2017) -
Pomalidomide enhances the maturation of dendritic cells derived from healthy donors and multiple myeloma patients
by: Xi Wang, et al.
Published: (2022) -
Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients-Real-World Data From Hungary
by: Szilvia Lovas, et al.
Published: (2022) -
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
by: Li Y, et al.
Published: (2017) -
Exposure‐response analyses for selection/confirmation of optimal isatuximab dosing regimen in combination with pomalidomide/dexamethasone treatment in patients with multiple myeloma
by: Fatiha Rachedi, et al.
Published: (2022)